Company intelligence / Profile preview

Pharma Action

Berlin, Berlin, Germany

Ownership: Private
Development stage: Other

Overview

Pharma Action is a German pharmaceutical manufacturing company focused on heparin and related biological extracts used for anticoagulation. The company has specialized in producing heparin active pharmaceutical ingredients from porcine raw materials with an emphasis on traceability from animal source to API production. Historically based in Berlin, Pharma Action operated as part of the Tönnies Group before being sold in 2017 to Bioibérica. Its business appears centered on commercial API manufacturing and supply rather than discovery-stage drug development, and it also has offered GMP-related services and sourcing support for the pharmaceutical industry.

Therapeutic areas: Cardiovascular
Modalities: Biologic
Industry: Contract Manufacturing Organization

Partnerships

Tönnies GroupBioibéricaSARIA Group

Beyond the preview

Go deeper on Pharma Action.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharma Action.

Explore the full profile